Immunotherapy
Virtual clinic provides rapid, specialized cancer care for patients facing adverse events
Many people who experience side effects from cancer treatment wait nearly a month to see a specialist with the necessary expertise.
World Lung Cancer Day: Risks of vaping; an ‘unprecedented’ advance in ALK-positive disease
Today is World Lung Cancer Day.
Top in endocrinology: Compounded semaglutide dosing errors; type 1 diabetes immunotherapy
The FDA has received reports of adverse events, including gastrointestinal events, fainting, headache, migraine, dehydration, acute pancreatitis and gallstones, that may be tied to overdosing with compounded semaglutide.
Combination extends survival in advanced ovarian cancer
The addition of an investigational immunotherapy to chemotherapy prolonged survival for women with advanced ovarian cancer, according to a topline data announcement.
Immunotherapy combination improves response in unresectable melanoma
An immunotherapy combination improved outcomes compared with historical control for certain patients with advanced melanoma, according to a topline data announcement.
ASTRO issues updated guideline for symptomatic bone metastases
The American Society for Radiation Oncology has issued an updated clinical guideline that outlines best practices for addressing symptomatic bone metastases and improving quality of life for these patients.
Novel immunotherapy creates ‘cancer-fighting cells,’ shrinks colon cancer tumors
A novel immunotherapy approach for solid, epithelial cancers reduced tumor burden among multiple patients with metastatic colon cancer, according to phase 2 study results.
Immunotherapy to treat early-stage type 1 diabetes receives FDA fast track designation
An immunotherapy to treat type 1 diabetes for people with the human leukocyte antigen DR3-DQ2 genotype received its second fast-track designation from the FDA, according to a company press release.